NEXTCHEM\'s proprietary NX AdWinMethanol® Zero offers an innovative process combining cutting-edge solutions to minimize carbon emissions,thanks to its autothermal reforming (ATR) technology
Feb 27, 2025
Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI,Feb. 26,2025-- Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (Fosun Pharma; stock code: 600196.SH,02196.HK) announced th
Feb 27, 2025
SANTA CLARA,Calif.,Feb. 26,2025-- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading AI cloud platform service provider,today announced its unaudited fin
Feb 27, 2025
HONG KONG,Feb. 27,2025-- HKBN Enterprise Solutions (HKBNES) has collaborated with Global Switch,a leading data centreoperator,to deliverhighly resilient and advanced data management solutions for ent
Feb 27, 2025
KUALA LUMPUR,Malaysia,Feb. 27,2025-- In collaboration with ASEAN Secretariat,the Ministry of Science and Technology of the People\'s Republic of China will host the 3rdChina-ASEAN Innovation and Entre
Feb 27, 2025
WUHAN,China,Feb. 24,2025--A report from ChangjiangDaily. VOYAH Ultra-Fast Charging Station Tops Global Speed Rankings
Feb 26, 2025
PARIS,Feb. 25,2025-- Little Artists Art Studio,is proud to share the historic debut of their young and rising talents at the prestigious Art Capital Paris: Le Salon des Artistes Français at the
Feb 26, 2025
Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference
Feb 26, 2025
6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023
Feb 26, 2025
SHANGHAI,Feb. 25,2025-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chin
Feb 26, 2025
New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t
Feb 26, 2025
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned
Feb 26, 2025
© Voice Of Zimbabwe Privacy Policy Contact us